Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,030,801
+$96,327 QoQ
Shares Held
23,586
-3.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,337
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVIS R M INC holds $148,422,330 across 9 Drug Manufacturers - General names. MRK ranks #4 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
61,458 | $73,714,575 | |
| 2 | JNJ |
Johnson & Johnson
|
249,911 | $63,469,896 | |
| 3 | ABBV |
AbbVie Inc.
|
18,009 | $4,531,784 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
23,586 | $3,030,801 | |
| 5 | AMGN |
Amgen Inc
|
6,701 | $2,426,566 | |
| 6 | AZN |
Astrazeneca PLC
|
1,871 | $354,779 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,425 | $312,588 | |
| 8 | PFE |
Pfizer Inc
|
12,484 | $300,614 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,030,801 | 23,586 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,934,474 | 24,395 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,536,029 | 24,093 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,216,087 | 26,404 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,107,346 | 39,254 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,488,570 | 72,288 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $16,548,000 | 166,345 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $35,488,749 | 312,511 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $39,583,688 | 319,739 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $42,022,908 | 318,476 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $34,856,964 | 319,730 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $33,393,376 | 324,365 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $36,957,109 | 320,280 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $33,849,255 | 318,162 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $35,037,122 | 315,792 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,927,915 | 312,679 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $27,960,106 | 306,681 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $24,949,599 | 304,078 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $23,048,866 | 300,742 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $21,970,350 | 292,509 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $22,730,226 | 292,275 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $22,504,047 | 291,919 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $23,809,597 | 291,071 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $25,396,564 | 306,167 | Shares | Sole | 2020-12-01 | |
| 2020-06-30 | $22,824,655 | 295,159 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $22,012,217 | 286,096 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||